evodiamine has been researched along with Liver Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SJ; Kim, YW; Song, YR; Yun, UJ | 1 |
| Chen, DL; Guo, XX; Hu, L; Jiang, R; Li, DY; Li, J; Li, LS; Ran, JH; Tang, JF; Xu, K; Zeng, D; Zhao, S; Zhou, P | 1 |
| Deng, J; Fan, X; Hao, X; Lei, F; Li, J; Liang, Y; Liang, Z; Liu, D; Shi, T; Wang, Z; Wen, H; Zhang, H | 1 |
| Chang, CJ; Hu, CY; Lin, CH; Su, YC; Wu, CL; Wu, HT | 1 |
| Chen, JL; Hu, X; Li, QY; Li, YL; Rao, MJ; Wu, LW; Yan, W; Zhang, B; Zhang, C; Zhang, NY | 1 |
| Chen, DL; Chen, Y; Guo, XX; Jiang, R; Li, DY; Li, J; Li, XP; Lyu, XT; Lyu, YW; Ran, JH; Tian, K; Yuan, DZ; Zhou, P | 1 |
| Deng, JD; Hu, XL; Jiang, Y; Lei, S; Tan, W; Wang, Z; Wen, HX; Zhang, HH | 1 |
| Ge, K; Jia, C; Lu, J; Zhu, H | 1 |
| Liao, H; Liu, Y; You, Z; Zahng, J | 1 |
| Liu, Q; Liu, Y; Luo, F; Shi, L; Yang, F; Zhang, F; Zou, M | 1 |
| Ji, L; Liang, T; Shen, Y; Shi, L; Xu, L; Yang, F; Zhang, G; Zhu, F | 1 |
| Han, X; Peng, JY; Qi, Y; Wang, XN; Xu, LN; Xu, YW; Yin, LH | 1 |
| Chang, CS; Chao, DC; Ho, TY; Hsiang, CY; Huang, HC; Kao, ST; Liang, JA; Lin, LJ; Wu, SL | 1 |
| Cai, X; Cao, P; Hu, C; Lu, W; Xu, X; Yang, J; Yu, Q | 1 |
14 other study(ies) available for evodiamine and Liver Neoplasms
| Article | Year |
|---|---|
A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mitochondria; Quinazolines; Up-Regulation; YAP-Signaling Proteins | 2022 |
Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Female; Hep G2 Cells; Hippo Signaling Pathway; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Serine-Threonine Kinases; Quinazolines; Signal Transduction; Transcription Factors; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2020 |
Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Molecular Structure; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Evodia; Gene Knockdown Techniques; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Plant Extracts; Quinazolines; WW Domain-Containing Oxidoreductase | 2017 |
Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Humans; Hydroxamic Acids; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Quinazolines; Vorinostat | 2018 |
Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
Topics: Animals; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Nod1 Signaling Adaptor Protein; Quinazolines; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
A concise synthesis and biological study of evodiamine and its analogues.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemistry Techniques, Synthetic; Evodia; Humans; Liver Neoplasms; Quinazolines | 2019 |
Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Down-Regulation; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Quinazolines; RNA, Messenger | 2019 |
[Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Quinazolines | 2014 |
Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; beta Catenin; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Evodia; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phytotherapy; Plant Extracts; Quinazolines; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Evodia; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines | 2017 |
Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Phytotherapy; Plant Extracts; Quinazolines; Tumor Necrosis Factor-alpha | 2008 |
Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Coptis; Drugs, Chinese Herbal; Evodia; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Plant Extracts; Quinazolines; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2011 |
Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Interleukin-6; Janus Kinase 2; Liver Neoplasms; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Quinazolines; RNA Interference; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Tyrphostins; Xenograft Model Antitumor Assays | 2013 |